BioTek Readers Receive BellBrook Certifications
News Sep 11, 2015
BioTek's complete line of multi-mode microplate readers have now earned Transcreener HTS Assay certifications from BellBrook Labs. Performance of BioTek readers including the Synergy™ Neo2 and Cytation™ 5 have been confirmed as meeting validation requirements across BellBrook's supported Fluorescence Intensity, Fluorescence Polarization and TR-FRET detection modes.
Synergy Neo2 is designed for speed and ultra high performance, incorporating BioTek's patented Hybrid Technology™, with its independent optical paths that ensure uncompromised performance in all detection modes. Continuously variable bandwidth quadruple monochromators, sensitive high transmission filter-based optics, and up to 4 PMTs provide ultra-fast measurements with excellent results.
Cytation 5 is a modular, upgradable multi-mode reader that combines automated digital microscopy and conventional microplate detection. Cytation 5 also incorporates BioTek’s patented Hybrid Technology with both filter- and monochromator-based detection; the microscopy module provides up to 60x magnification in fluorescence, brightfield, color brightfield and phase contrast.
Available laser autofocus and image-based autofocus ensures fast and accurate image acquisition with minimized phototoxicity across a broad application range.
Other BioTek readers earning the Transcreener certifications include Synergy™ H1, Synergy™ 2, and Synergy™ HTX.
Pine and Poplar Wood Improve Sunlight-Driven Water PurificationNews
Engineers have found that porous types of wood from trees like poplar and pine can greatly increase the efficiency of water-to-steam conversion under sunlight. The findings could be used in a simple and inexpensive biodegradable device for water purification.READ MORE
Closer Look at Immune Proteins Provides Insight into Potential Pathogen Protection StrategiesNews
Biologists have resolved the structure of a ring of proteins used by the immune system to summon support when under attack, providing new insight into potential strategies for protection from pathogens.READ MORE
Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing OrganizationNews
Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..READ MORE